Searched for
CADILLA
India to procure 27-28 crore COVID-19 vaccine doses in October: SourcesMeanwhile, the government said Zydus Cadila's indigenously-developed needle-free COVID-19 vaccine ZyCoV-D will be introduced in the nationw...- Hold Cadila Healthcare, target Rs 380: Emkay Global Financial ServicesHold Cadila Healthcare Ltd. at a price target of Rs 380.0 .
- Cadila gets US FDA warning for violating standards at Moraiya and Ahmedabad plantsThe company said its Moraiya and Ahmedabad facilities have been cited in the letter, and it is working on responding to the FDA concerns re...
- Secular prediction for pharma space difficult, Cadila's correction not a surprise: P Phani SekharWell, this is something that did not really come as a surprise to us. Well, this is something that did not really come as a surprise to us.
- Buy Cadilla with a target of Rs 1,880: Mitesh Thacker'Cadilla Ltd is a 'BUY' call with a target of Rs 1,880 and a stop loss of Rs 1,754'
- Claris surges 18% as pharma cos in race to buy injectible bizLupin, Cipla Zydus Cadilla and US-based Amneal are competing with other global peers signaling the continuing appeal of quality Indian phar...
- Indian firms invested $ 1.29 billion overseas in SeptemberAlok Industries, Simplex Infrastructures, Tata Petrodyne, Cadilla Healthcare, Piramal Enterprises, Mercator and Bharti Airtel were among th...
- Buy Cadilla Healthcare with a target of 904: Deepak MohoniCadilla Healthcare Ltd is a ‘BUY’ call with a target of Rs 904 and a stop loss of Rs 855.
- Bayer AG expects India sales to double by 2015Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period
- Lupin is a buy: Vikas Khemani, Edelweiss Securities LtdPharma space is a very good space and there is a reasonably good amount of growth visibility.
- Buy Cadilla Healthcare for target of Rs 768: AptartBuy Cadilla Healthcare in the range of Rs 740-735 with stoploss of Rs 728 for target of Rs 768. Price and volume breakout seen in the stock.
- India unveils first indigenous vaccine against swine fluIndia on Thursday unveiled its first indigenous vaccine against the dreaded swine flu which claimed over 18,000 lives globally and more tha...
- What to watch out forRBI is expected to leave interest rates unchanged this time, as a premature tightening may hurt the economic recovery.
- Zydus Cadila surges on drug discovery pact with Eli LillyShares of Zydus Cadila got a booster shot after the pharmaceutical company signed a new drug discovery and development agreement with Eli L...
- Stocks to watch: SBI, Reliance, Zydus CadillaEquities are likely to open lower on Monday following meltdown in overseas markets on fears of slow-down in global economy and recession in...
- Five pharma companies to face legal actionAlembic, Cadilla Healthcare, Wockhardt, Lupin and Medley Pharmaceuticals would face legal action for allegedly selling 39 specified pack si...
- No 'Sugar Free' for AmulHC restrains Gujarat Co-operative Milk Marketing Federation from using Cadila's trademark "Sugar Free".
- Zydus scouts for partners in Land of Rising SunThe company is in talks with 2-3 pharma companies and has earmarked an investment of about $25 million for its expansion plans in Japan.
- Fire breaks out in Cadila Pharma unitA major fire broke out in the Cadilla Pharmaceuticals unit at Ankleshwar city in Gujarat's Bharuch district.
- Indian pharma cos look to Europe for growthCountry's leading pharma companies are looking towards Europe for organic and inorganic growth with the US market, the largest one for Indi...
Load More
